Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis

Objective: Although some meta-analyses have shown a correlation between a high neutrophil-to-lymphocyte ratio (NLR) and low survival in patients with gliomas, their conclusions are controversial, and no study has specifically explored the relationship between a high pre-treatment and pre-operative N...

Full description

Bibliographic Details
Main Authors: Xin Guo, Hengxing Jiao, Tiantian Zhang, Yuelin Zhang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/12/5/675
_version_ 1797501173352103936
author Xin Guo
Hengxing Jiao
Tiantian Zhang
Yuelin Zhang
author_facet Xin Guo
Hengxing Jiao
Tiantian Zhang
Yuelin Zhang
author_sort Xin Guo
collection DOAJ
description Objective: Although some meta-analyses have shown a correlation between a high neutrophil-to-lymphocyte ratio (NLR) and low survival in patients with gliomas, their conclusions are controversial, and no study has specifically explored the relationship between a high pre-treatment and pre-operative NLR and low survival in patients with glioblastoma (GBM). Therefore, we further investigated this correlation through meta-analysis. Methods: We searched the PubMed, Metstr, and Cochrane databases in March 2022 for published literature related to high pre-treatment and pre-operative NLR and low survival in patients with GBM. The literature was rigorously searched according to inclusion and exclusion criteria to calculate the overall hazard ratio (HR) and 95% confidence interval (CI) corresponding to a high NLR using a random effects model. Results: The total HR for the pre-treatment and pre-operative NLR was 1.46 (95% CI: 1.17–1.75, <i>p</i> = 0.000, I<sup>2</sup> = 76.5%), indicating a significant association between a high pre-treatment and pre-operative NLR, and low overall survival in patients with GBM. Sub-group analysis was performed because of the high heterogeneity. The results for the sub-group with a cut-off value of 4 showed an HR of 1.39 (95% CI: 1.12–1.65, <i>p</i> = 0.000, I<sup>2</sup> = 22.2%), with significantly low heterogeneity, whereas those for the sub-group without a cut-off value of 4 showed an HR of 1.45 (95% CI: 1.01–1.89, <i>p</i> = 0.000, I<sup>2</sup> = 83.3%). Conclusions: The results of this study demonstrate that a high pre-treatment and pre-operative NLR suggests low survival in patients with GBM based on data from a large sample. Furthermore, the meta-regression analysis results indicate that underlying data, such as age and extent of surgical resection, lead to a high degree of heterogeneity, providing a theoretical basis for further research.
first_indexed 2024-03-10T03:14:33Z
format Article
id doaj.art-6ed294519de040b4a9dd938f7ba5eea3
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T03:14:33Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-6ed294519de040b4a9dd938f7ba5eea32023-11-23T10:18:50ZengMDPI AGBrain Sciences2076-34252022-05-0112567510.3390/brainsci12050675Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-AnalysisXin Guo0Hengxing Jiao1Tiantian Zhang2Yuelin Zhang3Department of Graduate Work, Hanguang Campus of Xi’an Medical University, Xi’an 710068, ChinaDepartment of Graduate Work, Hanguang Campus of Xi’an Medical University, Xi’an 710068, ChinaDepartment of Graduate Work, Hanguang Campus of Xi’an Medical University, Xi’an 710068, ChinaVice President of Xi’an Medical University, Weiyang Campus of Xi’an Medical University, Xi’an 710068, ChinaObjective: Although some meta-analyses have shown a correlation between a high neutrophil-to-lymphocyte ratio (NLR) and low survival in patients with gliomas, their conclusions are controversial, and no study has specifically explored the relationship between a high pre-treatment and pre-operative NLR and low survival in patients with glioblastoma (GBM). Therefore, we further investigated this correlation through meta-analysis. Methods: We searched the PubMed, Metstr, and Cochrane databases in March 2022 for published literature related to high pre-treatment and pre-operative NLR and low survival in patients with GBM. The literature was rigorously searched according to inclusion and exclusion criteria to calculate the overall hazard ratio (HR) and 95% confidence interval (CI) corresponding to a high NLR using a random effects model. Results: The total HR for the pre-treatment and pre-operative NLR was 1.46 (95% CI: 1.17–1.75, <i>p</i> = 0.000, I<sup>2</sup> = 76.5%), indicating a significant association between a high pre-treatment and pre-operative NLR, and low overall survival in patients with GBM. Sub-group analysis was performed because of the high heterogeneity. The results for the sub-group with a cut-off value of 4 showed an HR of 1.39 (95% CI: 1.12–1.65, <i>p</i> = 0.000, I<sup>2</sup> = 22.2%), with significantly low heterogeneity, whereas those for the sub-group without a cut-off value of 4 showed an HR of 1.45 (95% CI: 1.01–1.89, <i>p</i> = 0.000, I<sup>2</sup> = 83.3%). Conclusions: The results of this study demonstrate that a high pre-treatment and pre-operative NLR suggests low survival in patients with GBM based on data from a large sample. Furthermore, the meta-regression analysis results indicate that underlying data, such as age and extent of surgical resection, lead to a high degree of heterogeneity, providing a theoretical basis for further research.https://www.mdpi.com/2076-3425/12/5/675glioblastomaGBMglioblastoma multiformeNLRneutrophil-to-lymphocyte ratioprognostic
spellingShingle Xin Guo
Hengxing Jiao
Tiantian Zhang
Yuelin Zhang
Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
Brain Sciences
glioblastoma
GBM
glioblastoma multiforme
NLR
neutrophil-to-lymphocyte ratio
prognostic
title Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
title_full Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
title_fullStr Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
title_full_unstemmed Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
title_short Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
title_sort pre treatment and preoperative neutrophil to lymphocyte ratio predicts prognostic value of glioblastoma a meta analysis
topic glioblastoma
GBM
glioblastoma multiforme
NLR
neutrophil-to-lymphocyte ratio
prognostic
url https://www.mdpi.com/2076-3425/12/5/675
work_keys_str_mv AT xinguo pretreatmentandpreoperativeneutrophiltolymphocyteratiopredictsprognosticvalueofglioblastomaametaanalysis
AT hengxingjiao pretreatmentandpreoperativeneutrophiltolymphocyteratiopredictsprognosticvalueofglioblastomaametaanalysis
AT tiantianzhang pretreatmentandpreoperativeneutrophiltolymphocyteratiopredictsprognosticvalueofglioblastomaametaanalysis
AT yuelinzhang pretreatmentandpreoperativeneutrophiltolymphocyteratiopredictsprognosticvalueofglioblastomaametaanalysis